Arunjyothi Bio Ventures Limited

BSE:530881 Stock Report

Market Cap: ₹3.5b

Arunjyothi Bio Ventures Past Earnings Performance

Past criteria checks 2/6

Arunjyothi Bio Ventures has been growing earnings at an average annual rate of 34.9%, while the Trade Distributors industry saw earnings growing at 29.6% annually. Revenues have been growing at an average rate of 34.1% per year. Arunjyothi Bio Ventures's return on equity is 154.1%, and it has net margins of 8.8%.

Key information

34.9%

Earnings growth rate

-2.5%

EPS growth rate

Trade Distributors Industry Growth27.3%
Revenue growth rate34.1%
Return on equity154.1%
Net Margin8.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Arunjyothi Bio Ventures makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:530881 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2430927750
30 Jun 2427713560
31 Mar 24204-3470
31 Dec 23130-3270
30 Sep 2377-12120
30 Jun 2346320
31 Mar 2317100
31 Dec 225300
30 Sep 220210
30 Jun 227-100
31 Mar 2230110
31 Dec 2152-220
30 Sep 2161-320
30 Jun 2166020
31 Mar 2155120
31 Dec 2048110
30 Sep 2052200
30 Jun 2053110
31 Mar 2073130
31 Dec 1974-370
30 Sep 1979270
30 Jun 1968270
31 Mar 1937050
31 Dec 1821410
30 Sep 184-210
30 Jun 180-200
31 Mar 180-200
31 Dec 17137-1170
30 Sep 171970170
30 Jun 173121170
31 Mar 17393260
31 Dec 16256120
30 Sep 16198020
30 Jun 1683010
31 Mar 162-110
31 Dec 152000
30 Sep 150100
30 Jun 150000
31 Mar 150000
31 Dec 140010
30 Sep 141010
30 Jun 141000
31 Mar 141010

Quality Earnings: 530881 has a high level of non-cash earnings.

Growing Profit Margin: 530881 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 530881's earnings have grown significantly by 34.9% per year over the past 5 years.

Accelerating Growth: 530881 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 530881 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Trade Distributors industry (22.7%).


Return on Equity

High ROE: Whilst 530881's Return on Equity (154.08%) is outstanding, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 19:00
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arunjyothi Bio Ventures Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution